3,832 results on '"DARBEPOETIN alfa"'
Search Results
2. Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
3. Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)
4. Darbepoetin in Neonatal Encephalopathy Trial (EDEN)
5. Mechanisms of EPO-induced Hypertension (EPIC)
6. Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease Using the Dialysis Anemia TReatmenT Model (SMART)
7. A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis
8. Evaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease. (OPERA-CKD)
9. Efficacy of ferric carboxymaltose or darbepoetin alfa for chemotherapy-induced anemia in patients with esophagogastric or pancreaticobiliary cancer: a retrospective comparative study.
10. Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
11. Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
12. Mild Encephalopathy in the Newborn Treated With Darbepoetin (MEND)
13. Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants (Darbe)
14. Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration (DINOSAUR)
15. Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis
16. Evaluating the safety and efficacy of vadadustat for the treatment of anemia associated with chronic kidney disease.
17. Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
18. The effect of darbepoetin alfa on the glomerulus of new-born mice with intrauterine growth restriction
19. Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants (DIVI)
20. The Effect of Roxadustat on Renal Oxygenation in Diabetes Nephropathy (FOXTROT)
21. High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia
22. Successfully Managing Cats with Chronic Kidney Disease: MANAGING THE TWO A'S
23. Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease
24. Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
25. Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease
26. Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)
27. Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)
28. RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
29. Vafseo Approved for Anemia Due to CKD in Patients on Dialysis
30. Weight-based vs fixed dosing of darbepoetin alfa for anemia following kidney transplantation.
31. A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia
32. Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease (START-CKD)
33. Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
34. Amgen Sp. z o.o. (ORG) secures contract for Pharmaceutical Products - Package No. 1 - Darbepoetin Alfa
35. MINISTRY OF HEALTH, REMBAU HOSPITAL invites tenders for Quotation Supply and Send Supplies Darbepoetin Alfa 40mcg (prefilled Syringe) Injection to Rembau Hospital for Twenty -four (24) Months
36. AMGEN SA secures contract for Various Medicinal Products - Darbepoetin Alfa
37. Amgen GmbH secures contract for Pharmaceutical Products - Darbepoetin Alfa 40 Μg / 0.4 Ml Pre-Filled Syringe Or Pre-Filled Pen Pcs
38. Amgen GmbH secures contract for Pharmaceutical Products - Darbepoetin Alfa 80 Μg / 0.4 Ml Pre-Filled Syringe Or Pre-Filled Pen Pcs
39. Amgen GmbH secures contract for Pharmaceutical Products - Darbepoetin Alfa 60 Μg / 0.3 Ml Pre-Filled Syringe Or Pre-Filled Pen Pcs
40. Amgen GmbH secures contract for Pharmaceutical Products - Darbepoetin Alfa 500 Μg / 1.0 Ml Pre-Filled Syringe Or Pre-Filled Pen Pcs
41. Amgen GmbH secures contract for Pharmaceutical Products - Darbepoetin Alfa 20 Μg / 0.5 Ml Pre-Filled Syringe Or Pre-Filled Pen St
42. Amgen GmbH secures contract for Pharmaceutical Products - Darbepoetin Alfa 300 Μg / 0.6 Ml Pre-Filled Syringe Or Pre-Filled Pen Pcs
43. Amgen GmbH secures contract for Pharmaceutical Products - Darbepoetin Alfa 50 Μg / 0.5 Ml Pre-Filled Syringe Or Pre-Filled Pen St
44. Amgen GmbH secures contract for Pharmaceutical Products - Darbepoetin Alfa 100 Μg / 0.5 Ml Pre-Filled Syringe Or Pre-Filled Pen Pcs
45. Amgen GmbH secures contract for Pharmaceutical Products - Darbepoetin Alfa 30 Μg / 0.3 Ml Pre-Filled Syringe Or Pre-Filled Pen St
46. Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD)
47. Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
48. Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease
49. Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data
50. Desidustat in the Treatment of Anemia in CKD (DREAM-ND)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.